Global Encapsulated iPSC-Derived Islet Cell Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Encapsulated iPSC-Derived Islet Cell Therapy market size was valued at US$ 43.22 million in 2025 and is forecast to a readjusted size of US$ 572 million by 2032 with a CAGR of 44.9% during review period.
Encapsulated iPSC-Derived Islet Cell Therapy is a regenerative medicine approach in which human induced pluripotent stem cell (iPSC)-derived islet-like cells or ?-cell clusters are combined with immune-isolation devices, hydrogel microcapsules, bioprinted scaffolds, or localized immune-tolerance materials before implantation into the body. The therapy is designed to replace the damaged or absent pancreatic islet function in patients with type 1 diabetes and other insulin-dependent forms of diabetes. By sensing blood glucose levels and secreting insulin, glucagon, and other endocrine hormones, these therapies aim to restore physiological glucose regulation. Key product development priorities include cell maturation, endocrine cell purity, dosing strategy, glucose responsiveness, mass transfer performance of encapsulation materials, retrievability, immune protection efficacy, GMP batch consistency, and long-term safety. The overall gross margin is approximately 70%.
Demand for encapsulated iPSC-derived islet cell therapies is primarily driven by the unmet needs of patients with type 1 diabetes who require lifelong insulin therapy, face a high risk of severe hypoglycemia, have limited access to donor islets, and often require immunosuppressive treatment following transplantation. By combining a scalable iPSC-derived cell source with immune-protective encapsulation technologies, these therapies seek to achieve durable glycemic control without lifelong systemic immunosuppression. Their greatest clinical value lies in high-risk type 1 diabetes, brittle diabetes, and as a potential alternative to donor islet transplantation.
Competition is shifting from cell differentiation capability alone toward integrated expertise spanning cell biology, biomaterials, medical devices, and manufacturing processes. Macroencapsulation devices emphasize retrievability and clinical controllability, while hydrogel and microcapsule technologies focus on efficient nutrient and oxygen transport together with localized immune isolation. Bioprinted tissue constructs aim to recreate physiological cellular architecture, improve nutrient supply, and enhance long-term graft functionality after implantation. Key barriers throughout the supply chain include the establishment of clinical-grade iPSC banks, reproducible directed differentiation, biocompatible encapsulation materials, preservation of cell function under hypoxic conditions, and scalable GMP manufacturing systems.
Regional opportunities are primarily concentrated in the United States, Canada, Europe, and Israel, where regenerative medicine translation is advancing rapidly. In the near term, market activity is expected to remain focused on clinical trial supply, technology licensing, co-development partnerships, and manufacturing process validation. Commercial adoption will largely depend on the safety profile of first-generation products, C-peptide restoration, implant durability, device retrievability, and reimbursement acceptance. If encapsulation or immune-evasion strategies can substantially reduce or eliminate the need for immunosuppression, the eligible patient population and commercial potential of this therapeutic approach could expand significantly.
Report Scope
This report is a detailed and comprehensive analysis for global Encapsulated iPSC-Derived Islet Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Encapsulated iPSC-Derived Islet Cell Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Encapsulated iPSC-Derived Islet Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Encapsulated iPSC-Derived Islet Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Encapsulated iPSC-Derived Islet Cell Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Encapsulated iPSC-Derived Islet Cell Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Encapsulated iPSC-Derived Islet Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Encapsulated iPSC-Derived Islet Cell Therapy, with revenue, gross margin, and global market share of Encapsulated iPSC-Derived Islet Cell Therapy from 2021 to 2026.
Chapter 3, the Encapsulated iPSC-Derived Islet Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Encapsulated iPSC-Derived Islet Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Encapsulated iPSC-Derived Islet Cell Therapy.
Chapter 13, to describe Encapsulated iPSC-Derived Islet Cell Therapy research findings and conclusion.
Encapsulated iPSC-Derived Islet Cell Therapy is a regenerative medicine approach in which human induced pluripotent stem cell (iPSC)-derived islet-like cells or ?-cell clusters are combined with immune-isolation devices, hydrogel microcapsules, bioprinted scaffolds, or localized immune-tolerance materials before implantation into the body. The therapy is designed to replace the damaged or absent pancreatic islet function in patients with type 1 diabetes and other insulin-dependent forms of diabetes. By sensing blood glucose levels and secreting insulin, glucagon, and other endocrine hormones, these therapies aim to restore physiological glucose regulation. Key product development priorities include cell maturation, endocrine cell purity, dosing strategy, glucose responsiveness, mass transfer performance of encapsulation materials, retrievability, immune protection efficacy, GMP batch consistency, and long-term safety. The overall gross margin is approximately 70%.
Demand for encapsulated iPSC-derived islet cell therapies is primarily driven by the unmet needs of patients with type 1 diabetes who require lifelong insulin therapy, face a high risk of severe hypoglycemia, have limited access to donor islets, and often require immunosuppressive treatment following transplantation. By combining a scalable iPSC-derived cell source with immune-protective encapsulation technologies, these therapies seek to achieve durable glycemic control without lifelong systemic immunosuppression. Their greatest clinical value lies in high-risk type 1 diabetes, brittle diabetes, and as a potential alternative to donor islet transplantation.
Competition is shifting from cell differentiation capability alone toward integrated expertise spanning cell biology, biomaterials, medical devices, and manufacturing processes. Macroencapsulation devices emphasize retrievability and clinical controllability, while hydrogel and microcapsule technologies focus on efficient nutrient and oxygen transport together with localized immune isolation. Bioprinted tissue constructs aim to recreate physiological cellular architecture, improve nutrient supply, and enhance long-term graft functionality after implantation. Key barriers throughout the supply chain include the establishment of clinical-grade iPSC banks, reproducible directed differentiation, biocompatible encapsulation materials, preservation of cell function under hypoxic conditions, and scalable GMP manufacturing systems.
Regional opportunities are primarily concentrated in the United States, Canada, Europe, and Israel, where regenerative medicine translation is advancing rapidly. In the near term, market activity is expected to remain focused on clinical trial supply, technology licensing, co-development partnerships, and manufacturing process validation. Commercial adoption will largely depend on the safety profile of first-generation products, C-peptide restoration, implant durability, device retrievability, and reimbursement acceptance. If encapsulation or immune-evasion strategies can substantially reduce or eliminate the need for immunosuppression, the eligible patient population and commercial potential of this therapeutic approach could expand significantly.
Report Scope
This report is a detailed and comprehensive analysis for global Encapsulated iPSC-Derived Islet Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Encapsulated iPSC-Derived Islet Cell Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Encapsulated iPSC-Derived Islet Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Encapsulated iPSC-Derived Islet Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Encapsulated iPSC-Derived Islet Cell Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Encapsulated iPSC-Derived Islet Cell Therapy
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Encapsulated iPSC-Derived Islet Cell Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Macroencapsulation Device Therapy
- Hydrogel Microencapsulation Therapy
- Conformal Coating Encapsulation Therapy
- Bioprinted Encapsulated Tissue Therapy
- Local Immune Tolerance Matrix Therapy
- Other Encapsulation Architectures
- Pancreatic Endoderm Cells
- Immature Endocrine Progenitors
- Beta Cell-Enriched Clusters
- Islet-Like Endocrine Clusters
- Mature Multihormonal Islet Cells
- Other Maturity Stages
- Physical Immune Isolation
- Local Immune Tolerance
- Hypoimmune Gene Editing
- Encapsulation Plus Gene Editing
- Systemic Immunosuppression-Enabled
- Other Immune Strategies
- Discovery Research
- Preclinical Development
- IND-Enabling Development
- Phase 1/2 Clinical Stage
- Pivotal and Registration Stage
- Discontinued or Legacy Assets
- Type 1 Diabetes
- Brittle Diabetes
- Insulin-Dependent Type 2 Diabetes
- Post-Pancreatectomy Diabetes
- Islet Replacement Research
- Other Diabetes Indications
- Vertex Pharmaceuticals
- Aspect Biosystems
- Sernova
- Evotec
- Sana Biotechnology
- Kadimastem
- iTolerance
- Seraxis
- CRISPR Therapeutics
- Novo Nordisk
- Eli Lilly
- Sigilon Therapeutics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Encapsulated iPSC-Derived Islet Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Encapsulated iPSC-Derived Islet Cell Therapy, with revenue, gross margin, and global market share of Encapsulated iPSC-Derived Islet Cell Therapy from 2021 to 2026.
Chapter 3, the Encapsulated iPSC-Derived Islet Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Encapsulated iPSC-Derived Islet Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Encapsulated iPSC-Derived Islet Cell Therapy.
Chapter 13, to describe Encapsulated iPSC-Derived Islet Cell Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Type
1.3.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type in 2025
1.3.3 Macroencapsulation Device Therapy
1.3.4 Hydrogel Microencapsulation Therapy
1.3.5 Conformal Coating Encapsulation Therapy
1.3.6 Bioprinted Encapsulated Tissue Therapy
1.3.7 Local Immune Tolerance Matrix Therapy
1.3.8 Other Encapsulation Architectures
1.4 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Cell Maturity Stage
1.4.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage: 2021 Versus 2025 Versus 2032
1.4.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Cell Maturity Stage in 2025
1.4.3 Pancreatic Endoderm Cells
1.4.4 Immature Endocrine Progenitors
1.4.5 Beta Cell-Enriched Clusters
1.4.6 Islet-Like Endocrine Clusters
1.4.7 Mature Multihormonal Islet Cells
1.4.8 Other Maturity Stages
1.5 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Immune Protection Strategy
1.5.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy: 2021 Versus 2025 Versus 2032
1.5.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Immune Protection Strategy in 2025
1.5.3 Physical Immune Isolation
1.5.4 Local Immune Tolerance
1.5.5 Hypoimmune Gene Editing
1.5.6 Encapsulation Plus Gene Editing
1.5.7 Systemic Immunosuppression-Enabled
1.5.8 Other Immune Strategies
1.6 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Development Stage
1.6.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage: 2021 Versus 2025 Versus 2032
1.6.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Development Stage in 2025
1.6.3 Discovery Research
1.6.4 Preclinical Development
1.6.5 IND-Enabling Development
1.6.6 Phase 1/2 Clinical Stage
1.6.7 Pivotal and Registration Stage
1.6.8 Discontinued or Legacy Assets
1.7 Global Encapsulated iPSC-Derived Islet Cell Therapy Market by Application
1.7.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Type 1 Diabetes
1.7.3 Brittle Diabetes
1.7.4 Insulin-Dependent Type 2 Diabetes
1.7.5 Post-Pancreatectomy Diabetes
1.7.6 Islet Replacement Research
1.7.7 Other Diabetes Indications
1.8 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size & Forecast
1.9 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast by Region
1.9.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region, (2021-2032)
1.9.3 North America Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.4 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.6 South America Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Vertex Pharmaceuticals
2.1.1 Vertex Pharmaceuticals Details
2.1.2 Vertex Pharmaceuticals Major Business
2.1.3 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.1.4 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Vertex Pharmaceuticals Recent Developments and Future Plans
2.2 Aspect Biosystems
2.2.1 Aspect Biosystems Details
2.2.2 Aspect Biosystems Major Business
2.2.3 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.2.4 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Aspect Biosystems Recent Developments and Future Plans
2.3 Sernova
2.3.1 Sernova Details
2.3.2 Sernova Major Business
2.3.3 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.3.4 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sernova Recent Developments and Future Plans
2.4 Evotec
2.4.1 Evotec Details
2.4.2 Evotec Major Business
2.4.3 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.4.4 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Evotec Recent Developments and Future Plans
2.5 Sana Biotechnology
2.5.1 Sana Biotechnology Details
2.5.2 Sana Biotechnology Major Business
2.5.3 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.5.4 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sana Biotechnology Recent Developments and Future Plans
2.6 Kadimastem
2.6.1 Kadimastem Details
2.6.2 Kadimastem Major Business
2.6.3 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.6.4 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Kadimastem Recent Developments and Future Plans
2.7 iTolerance
2.7.1 iTolerance Details
2.7.2 iTolerance Major Business
2.7.3 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.7.4 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 iTolerance Recent Developments and Future Plans
2.8 Seraxis
2.8.1 Seraxis Details
2.8.2 Seraxis Major Business
2.8.3 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.8.4 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Seraxis Recent Developments and Future Plans
2.9 CRISPR Therapeutics
2.9.1 CRISPR Therapeutics Details
2.9.2 CRISPR Therapeutics Major Business
2.9.3 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.9.4 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CRISPR Therapeutics Recent Developments and Future Plans
2.10 Novo Nordisk
2.10.1 Novo Nordisk Details
2.10.2 Novo Nordisk Major Business
2.10.3 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.10.4 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Novo Nordisk Recent Developments and Future Plans
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.11.4 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Eli Lilly Recent Developments and Future Plans
2.12 Sigilon Therapeutics
2.12.1 Sigilon Therapeutics Details
2.12.2 Sigilon Therapeutics Major Business
2.12.3 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.12.4 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sigilon Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Encapsulated iPSC-Derived Islet Cell Therapy by Company Revenue
3.2.2 Top 3 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
3.2.3 Top 6 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
3.3 Encapsulated iPSC-Derived Islet Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Encapsulated iPSC-Derived Islet Cell Therapy Market: Region Footprint
3.3.2 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
3.3.3 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value and Market Share by Type (2021-2026)
4.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2026)
5.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
6.2 North America Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2032)
6.3 North America Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
6.3.1 North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
6.3.2 United States Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
6.3.3 Canada Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
6.3.4 Mexico Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
7.2 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
7.3 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
7.3.1 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
7.3.2 Germany Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.3 France Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.5 Russia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.6 Italy Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2032)
8.3.2 China Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.3 Japan Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.4 South Korea Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.5 India Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.7 Australia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
9.2 South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
9.3 South America Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
9.3.1 South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
9.3.2 Brazil Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
9.3.3 Argentina Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
10.3.2 Turkey Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
10.3.4 UAE Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
11.2 Encapsulated iPSC-Derived Islet Cell Therapy Market Restraints
11.3 Encapsulated iPSC-Derived Islet Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Encapsulated iPSC-Derived Islet Cell Therapy Industry Chain
12.2 Encapsulated iPSC-Derived Islet Cell Therapy Upstream Analysis
12.3 Encapsulated iPSC-Derived Islet Cell Therapy Midstream Analysis
12.4 Encapsulated iPSC-Derived Islet Cell Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Type
1.3.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type in 2025
1.3.3 Macroencapsulation Device Therapy
1.3.4 Hydrogel Microencapsulation Therapy
1.3.5 Conformal Coating Encapsulation Therapy
1.3.6 Bioprinted Encapsulated Tissue Therapy
1.3.7 Local Immune Tolerance Matrix Therapy
1.3.8 Other Encapsulation Architectures
1.4 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Cell Maturity Stage
1.4.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Cell Maturity Stage: 2021 Versus 2025 Versus 2032
1.4.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Cell Maturity Stage in 2025
1.4.3 Pancreatic Endoderm Cells
1.4.4 Immature Endocrine Progenitors
1.4.5 Beta Cell-Enriched Clusters
1.4.6 Islet-Like Endocrine Clusters
1.4.7 Mature Multihormonal Islet Cells
1.4.8 Other Maturity Stages
1.5 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Immune Protection Strategy
1.5.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Immune Protection Strategy: 2021 Versus 2025 Versus 2032
1.5.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Immune Protection Strategy in 2025
1.5.3 Physical Immune Isolation
1.5.4 Local Immune Tolerance
1.5.5 Hypoimmune Gene Editing
1.5.6 Encapsulation Plus Gene Editing
1.5.7 Systemic Immunosuppression-Enabled
1.5.8 Other Immune Strategies
1.6 Classification of Encapsulated iPSC-Derived Islet Cell Therapy by Development Stage
1.6.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Development Stage: 2021 Versus 2025 Versus 2032
1.6.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Development Stage in 2025
1.6.3 Discovery Research
1.6.4 Preclinical Development
1.6.5 IND-Enabling Development
1.6.6 Phase 1/2 Clinical Stage
1.6.7 Pivotal and Registration Stage
1.6.8 Discontinued or Legacy Assets
1.7 Global Encapsulated iPSC-Derived Islet Cell Therapy Market by Application
1.7.1 Overview: Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Type 1 Diabetes
1.7.3 Brittle Diabetes
1.7.4 Insulin-Dependent Type 2 Diabetes
1.7.5 Post-Pancreatectomy Diabetes
1.7.6 Islet Replacement Research
1.7.7 Other Diabetes Indications
1.8 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size & Forecast
1.9 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast by Region
1.9.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region, (2021-2032)
1.9.3 North America Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.4 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.6 South America Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Vertex Pharmaceuticals
2.1.1 Vertex Pharmaceuticals Details
2.1.2 Vertex Pharmaceuticals Major Business
2.1.3 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.1.4 Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Vertex Pharmaceuticals Recent Developments and Future Plans
2.2 Aspect Biosystems
2.2.1 Aspect Biosystems Details
2.2.2 Aspect Biosystems Major Business
2.2.3 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.2.4 Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Aspect Biosystems Recent Developments and Future Plans
2.3 Sernova
2.3.1 Sernova Details
2.3.2 Sernova Major Business
2.3.3 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.3.4 Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sernova Recent Developments and Future Plans
2.4 Evotec
2.4.1 Evotec Details
2.4.2 Evotec Major Business
2.4.3 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.4.4 Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Evotec Recent Developments and Future Plans
2.5 Sana Biotechnology
2.5.1 Sana Biotechnology Details
2.5.2 Sana Biotechnology Major Business
2.5.3 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.5.4 Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sana Biotechnology Recent Developments and Future Plans
2.6 Kadimastem
2.6.1 Kadimastem Details
2.6.2 Kadimastem Major Business
2.6.3 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.6.4 Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Kadimastem Recent Developments and Future Plans
2.7 iTolerance
2.7.1 iTolerance Details
2.7.2 iTolerance Major Business
2.7.3 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.7.4 iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 iTolerance Recent Developments and Future Plans
2.8 Seraxis
2.8.1 Seraxis Details
2.8.2 Seraxis Major Business
2.8.3 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.8.4 Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Seraxis Recent Developments and Future Plans
2.9 CRISPR Therapeutics
2.9.1 CRISPR Therapeutics Details
2.9.2 CRISPR Therapeutics Major Business
2.9.3 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.9.4 CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CRISPR Therapeutics Recent Developments and Future Plans
2.10 Novo Nordisk
2.10.1 Novo Nordisk Details
2.10.2 Novo Nordisk Major Business
2.10.3 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.10.4 Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Novo Nordisk Recent Developments and Future Plans
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.11.4 Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Eli Lilly Recent Developments and Future Plans
2.12 Sigilon Therapeutics
2.12.1 Sigilon Therapeutics Details
2.12.2 Sigilon Therapeutics Major Business
2.12.3 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
2.12.4 Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sigilon Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Encapsulated iPSC-Derived Islet Cell Therapy by Company Revenue
3.2.2 Top 3 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
3.2.3 Top 6 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
3.3 Encapsulated iPSC-Derived Islet Cell Therapy Market: Overall Company Footprint Analysis
3.3.1 Encapsulated iPSC-Derived Islet Cell Therapy Market: Region Footprint
3.3.2 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
3.3.3 Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value and Market Share by Type (2021-2026)
4.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2026)
5.2 Global Encapsulated iPSC-Derived Islet Cell Therapy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
6.2 North America Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Application (2021-2032)
6.3 North America Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
6.3.1 North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
6.3.2 United States Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
6.3.3 Canada Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
6.3.4 Mexico Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
7.2 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
7.3 Europe Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
7.3.1 Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
7.3.2 Germany Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.3 France Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.5 Russia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
7.3.6 Italy Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2032)
8.3.2 China Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.3 Japan Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.4 South Korea Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.5 India Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
8.3.7 Australia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
9.2 South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
9.3 South America Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
9.3.1 South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
9.3.2 Brazil Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
9.3.3 Argentina Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2032)
10.3.2 Turkey Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
10.3.4 UAE Encapsulated iPSC-Derived Islet Cell Therapy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
11.2 Encapsulated iPSC-Derived Islet Cell Therapy Market Restraints
11.3 Encapsulated iPSC-Derived Islet Cell Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Encapsulated iPSC-Derived Islet Cell Therapy Industry Chain
12.2 Encapsulated iPSC-Derived Islet Cell Therapy Upstream Analysis
12.3 Encapsulated iPSC-Derived Islet Cell Therapy Midstream Analysis
12.4 Encapsulated iPSC-Derived Islet Cell Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Table 3. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Table 4. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 5. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Vertex Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 9. Vertex Pharmaceuticals Major Business
Table 10. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 11. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Vertex Pharmaceuticals Recent Developments and Future Plans
Table 13. Aspect Biosystems Company Information, Head Office, and Major Competitors
Table 14. Aspect Biosystems Major Business
Table 15. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 16. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Aspect Biosystems Recent Developments and Future Plans
Table 18. Sernova Company Information, Head Office, and Major Competitors
Table 19. Sernova Major Business
Table 20. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 21. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Evotec Company Information, Head Office, and Major Competitors
Table 23. Evotec Major Business
Table 24. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 25. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. Evotec Recent Developments and Future Plans
Table 27. Sana Biotechnology Company Information, Head Office, and Major Competitors
Table 28. Sana Biotechnology Major Business
Table 29. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 30. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Sana Biotechnology Recent Developments and Future Plans
Table 32. Kadimastem Company Information, Head Office, and Major Competitors
Table 33. Kadimastem Major Business
Table 34. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 35. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Kadimastem Recent Developments and Future Plans
Table 37. iTolerance Company Information, Head Office, and Major Competitors
Table 38. iTolerance Major Business
Table 39. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 40. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. iTolerance Recent Developments and Future Plans
Table 42. Seraxis Company Information, Head Office, and Major Competitors
Table 43. Seraxis Major Business
Table 44. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 45. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Seraxis Recent Developments and Future Plans
Table 47. CRISPR Therapeutics Company Information, Head Office, and Major Competitors
Table 48. CRISPR Therapeutics Major Business
Table 49. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 50. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. CRISPR Therapeutics Recent Developments and Future Plans
Table 52. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 53. Novo Nordisk Major Business
Table 54. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 55. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Novo Nordisk Recent Developments and Future Plans
Table 57. Eli Lilly Company Information, Head Office, and Major Competitors
Table 58. Eli Lilly Major Business
Table 59. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 60. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Eli Lilly Recent Developments and Future Plans
Table 62. Sigilon Therapeutics Company Information, Head Office, and Major Competitors
Table 63. Sigilon Therapeutics Major Business
Table 64. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 65. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. Sigilon Therapeutics Recent Developments and Future Plans
Table 67. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million) by Players (2021-2026)
Table 68. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Share by Players (2021-2026)
Table 69. Breakdown of Encapsulated iPSC-Derived Islet Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 70. Market Position of Players in Encapsulated iPSC-Derived Islet Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 71. Head Office of Key Encapsulated iPSC-Derived Islet Cell Therapy Players
Table 72. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
Table 73. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
Table 74. Encapsulated iPSC-Derived Islet Cell Therapy New Market Entrants and Barriers to Market Entry
Table 75. Encapsulated iPSC-Derived Islet Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 76. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (USD Million) by Type (2021-2026)
Table 77. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Share by Type (2021-2026)
Table 78. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Type (2027-2032)
Table 79. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026)
Table 80. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Application (2027-2032)
Table 81. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 82. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 83. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 84. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 85. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 86. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 92. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 93. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 94. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 95. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 96. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 97. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 99. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 100. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 101. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 102. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 103. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 104. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 106. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 107. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Global Key Players of Encapsulated iPSC-Derived Islet Cell Therapy Upstream (Raw Materials)
Table 112. Global Encapsulated iPSC-Derived Islet Cell Therapy Typical Customers
Table 1. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Table 3. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Table 4. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 5. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Vertex Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 9. Vertex Pharmaceuticals Major Business
Table 10. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 11. Vertex Pharmaceuticals Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Vertex Pharmaceuticals Recent Developments and Future Plans
Table 13. Aspect Biosystems Company Information, Head Office, and Major Competitors
Table 14. Aspect Biosystems Major Business
Table 15. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 16. Aspect Biosystems Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Aspect Biosystems Recent Developments and Future Plans
Table 18. Sernova Company Information, Head Office, and Major Competitors
Table 19. Sernova Major Business
Table 20. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 21. Sernova Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Evotec Company Information, Head Office, and Major Competitors
Table 23. Evotec Major Business
Table 24. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 25. Evotec Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. Evotec Recent Developments and Future Plans
Table 27. Sana Biotechnology Company Information, Head Office, and Major Competitors
Table 28. Sana Biotechnology Major Business
Table 29. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 30. Sana Biotechnology Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Sana Biotechnology Recent Developments and Future Plans
Table 32. Kadimastem Company Information, Head Office, and Major Competitors
Table 33. Kadimastem Major Business
Table 34. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 35. Kadimastem Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Kadimastem Recent Developments and Future Plans
Table 37. iTolerance Company Information, Head Office, and Major Competitors
Table 38. iTolerance Major Business
Table 39. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 40. iTolerance Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. iTolerance Recent Developments and Future Plans
Table 42. Seraxis Company Information, Head Office, and Major Competitors
Table 43. Seraxis Major Business
Table 44. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 45. Seraxis Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Seraxis Recent Developments and Future Plans
Table 47. CRISPR Therapeutics Company Information, Head Office, and Major Competitors
Table 48. CRISPR Therapeutics Major Business
Table 49. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 50. CRISPR Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. CRISPR Therapeutics Recent Developments and Future Plans
Table 52. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 53. Novo Nordisk Major Business
Table 54. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 55. Novo Nordisk Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Novo Nordisk Recent Developments and Future Plans
Table 57. Eli Lilly Company Information, Head Office, and Major Competitors
Table 58. Eli Lilly Major Business
Table 59. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 60. Eli Lilly Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Eli Lilly Recent Developments and Future Plans
Table 62. Sigilon Therapeutics Company Information, Head Office, and Major Competitors
Table 63. Sigilon Therapeutics Major Business
Table 64. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Product and Solutions
Table 65. Sigilon Therapeutics Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. Sigilon Therapeutics Recent Developments and Future Plans
Table 67. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue (USD Million) by Players (2021-2026)
Table 68. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Share by Players (2021-2026)
Table 69. Breakdown of Encapsulated iPSC-Derived Islet Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 70. Market Position of Players in Encapsulated iPSC-Derived Islet Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 71. Head Office of Key Encapsulated iPSC-Derived Islet Cell Therapy Players
Table 72. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Type Footprint
Table 73. Encapsulated iPSC-Derived Islet Cell Therapy Market: Company Product Application Footprint
Table 74. Encapsulated iPSC-Derived Islet Cell Therapy New Market Entrants and Barriers to Market Entry
Table 75. Encapsulated iPSC-Derived Islet Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 76. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (USD Million) by Type (2021-2026)
Table 77. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Share by Type (2021-2026)
Table 78. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Type (2027-2032)
Table 79. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026)
Table 80. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Forecast by Application (2027-2032)
Table 81. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 82. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 83. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 84. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 85. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 86. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 92. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 93. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 94. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 95. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 96. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 97. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 99. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 100. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 101. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 102. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 103. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 104. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 106. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 107. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Global Key Players of Encapsulated iPSC-Derived Islet Cell Therapy Upstream (Raw Materials)
Table 112. Global Encapsulated iPSC-Derived Islet Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. Encapsulated iPSC-Derived Islet Cell Therapy Picture
Figure 2. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type in 2025
Figure 4. Macroencapsulation Device Therapy
Figure 5. Hydrogel Microencapsulation Therapy
Figure 6. Conformal Coating Encapsulation Therapy
Figure 7. Bioprinted Encapsulated Tissue Therapy
Figure 8. Local Immune Tolerance Matrix Therapy
Figure 9. Other Encapsulation Architectures
Figure 10. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Cell Maturity Stage in 2025
Figure 12. Pancreatic Endoderm Cells
Figure 13. Immature Endocrine Progenitors
Figure 14. Beta Cell-Enriched Clusters
Figure 15. Islet-Like Endocrine Clusters
Figure 16. Mature Multihormonal Islet Cells
Figure 17. Other Maturity Stages
Figure 18. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Figure 19. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Immune Protection Strategy in 2025
Figure 20. Physical Immune Isolation
Figure 21. Local Immune Tolerance
Figure 22. Hypoimmune Gene Editing
Figure 23. Encapsulation Plus Gene Editing
Figure 24. Systemic Immunosuppression-Enabled
Figure 25. Other Immune Strategies
Figure 26. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 27. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Development Stage in 2025
Figure 28. Discovery Research
Figure 29. Preclinical Development
Figure 30. IND-Enabling Development
Figure 31. Phase 1/2 Clinical Stage
Figure 32. Pivotal and Registration Stage
Figure 33. Discontinued or Legacy Assets
Figure 34. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application in 2025
Figure 36. Type 1 Diabetes Picture
Figure 37. Brittle Diabetes Picture
Figure 38. Insulin-Dependent Type 2 Diabetes Picture
Figure 39. Post-Pancreatectomy Diabetes Picture
Figure 40. Islet Replacement Research Picture
Figure 41. Other Diabetes Indications Picture
Figure 42. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 43. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 44. Global Market Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 45. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 46. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region in 2025
Figure 47. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 50. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 51. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 52. Company Three Recent Developments and Future Plans
Figure 53. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Share by Players in 2025
Figure 54. Encapsulated iPSC-Derived Islet Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 55. Market Share of Encapsulated iPSC-Derived Islet Cell Therapy by Player Revenue in 2025
Figure 56. Top 3 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
Figure 57. Top 6 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
Figure 58. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Share by Type (2021-2026)
Figure 59. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Share Forecast by Type (2027-2032)
Figure 60. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Share by Application (2021-2026)
Figure 61. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Share Forecast by Application (2027-2032)
Figure 62. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 63. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 64. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 65. United States Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 66. Canada Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 67. Mexico Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 68. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 69. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 70. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 71. Germany Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 72. France Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 73. United Kingdom Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 74. Russia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 75. Italy Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 76. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 77. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 78. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 79. China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 80. Japan Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 81. South Korea Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 82. India Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 83. Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 84. Australia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 85. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 86. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 87. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 88. Brazil Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 89. Argentina Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 90. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 91. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 92. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 93. Turkey Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 94. Saudi Arabia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 95. UAE Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 96. Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
Figure 97. Encapsulated iPSC-Derived Islet Cell Therapy Market Restraints
Figure 98. Encapsulated iPSC-Derived Islet Cell Therapy Market Trends
Figure 99. Porters Five Forces Analysis
Figure 100. Encapsulated iPSC-Derived Islet Cell Therapy Industrial Chain
Figure 101. Methodology
Figure 102. Research Process and Data Source
Figure 1. Encapsulated iPSC-Derived Islet Cell Therapy Picture
Figure 2. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type in 2025
Figure 4. Macroencapsulation Device Therapy
Figure 5. Hydrogel Microencapsulation Therapy
Figure 6. Conformal Coating Encapsulation Therapy
Figure 7. Bioprinted Encapsulated Tissue Therapy
Figure 8. Local Immune Tolerance Matrix Therapy
Figure 9. Other Encapsulation Architectures
Figure 10. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Cell Maturity Stage, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Cell Maturity Stage in 2025
Figure 12. Pancreatic Endoderm Cells
Figure 13. Immature Endocrine Progenitors
Figure 14. Beta Cell-Enriched Clusters
Figure 15. Islet-Like Endocrine Clusters
Figure 16. Mature Multihormonal Islet Cells
Figure 17. Other Maturity Stages
Figure 18. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Immune Protection Strategy, (USD Million), 2021 & 2025 & 2032
Figure 19. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Immune Protection Strategy in 2025
Figure 20. Physical Immune Isolation
Figure 21. Local Immune Tolerance
Figure 22. Hypoimmune Gene Editing
Figure 23. Encapsulation Plus Gene Editing
Figure 24. Systemic Immunosuppression-Enabled
Figure 25. Other Immune Strategies
Figure 26. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 27. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Development Stage in 2025
Figure 28. Discovery Research
Figure 29. Preclinical Development
Figure 30. IND-Enabling Development
Figure 31. Phase 1/2 Clinical Stage
Figure 32. Pivotal and Registration Stage
Figure 33. Discontinued or Legacy Assets
Figure 34. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application in 2025
Figure 36. Type 1 Diabetes Picture
Figure 37. Brittle Diabetes Picture
Figure 38. Insulin-Dependent Type 2 Diabetes Picture
Figure 39. Post-Pancreatectomy Diabetes Picture
Figure 40. Islet Replacement Research Picture
Figure 41. Other Diabetes Indications Picture
Figure 42. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 43. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 44. Global Market Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 45. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 46. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region in 2025
Figure 47. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 50. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 51. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 52. Company Three Recent Developments and Future Plans
Figure 53. Global Encapsulated iPSC-Derived Islet Cell Therapy Revenue Share by Players in 2025
Figure 54. Encapsulated iPSC-Derived Islet Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 55. Market Share of Encapsulated iPSC-Derived Islet Cell Therapy by Player Revenue in 2025
Figure 56. Top 3 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
Figure 57. Top 6 Encapsulated iPSC-Derived Islet Cell Therapy Players Market Share in 2025
Figure 58. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Share by Type (2021-2026)
Figure 59. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Share Forecast by Type (2027-2032)
Figure 60. Global Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Share by Application (2021-2026)
Figure 61. Global Encapsulated iPSC-Derived Islet Cell Therapy Market Share Forecast by Application (2027-2032)
Figure 62. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 63. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 64. North America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 65. United States Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 66. Canada Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 67. Mexico Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 68. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 69. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 70. Europe Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 71. Germany Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 72. France Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 73. United Kingdom Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 74. Russia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 75. Italy Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 76. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 77. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 78. Asia-Pacific Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Region (2021-2032)
Figure 79. China Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 80. Japan Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 81. South Korea Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 82. India Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 83. Southeast Asia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 84. Australia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 85. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 86. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 87. South America Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 88. Brazil Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 89. Argentina Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 90. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Type (2021-2032)
Figure 91. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Application (2021-2032)
Figure 92. Middle East & Africa Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value Market Share by Country (2021-2032)
Figure 93. Turkey Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 94. Saudi Arabia Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 95. UAE Encapsulated iPSC-Derived Islet Cell Therapy Consumption Value (2021-2032) & (USD Million)
Figure 96. Encapsulated iPSC-Derived Islet Cell Therapy Market Drivers
Figure 97. Encapsulated iPSC-Derived Islet Cell Therapy Market Restraints
Figure 98. Encapsulated iPSC-Derived Islet Cell Therapy Market Trends
Figure 99. Porters Five Forces Analysis
Figure 100. Encapsulated iPSC-Derived Islet Cell Therapy Industrial Chain
Figure 101. Methodology
Figure 102. Research Process and Data Source
